T Muramatsu Selected Research

T Muramatsu Research Topics

Disease

14	Neoplasms (Cancer) 10/2016 - 01/2000
9	Carcinoma (Carcinomatosis) 02/2003 - 01/2000
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2016 - 01/2000
4	Carcinogenesis 05/2014 - 03/2001
3	Wounds and Injuries (Trauma) 04/2018 - 08/2009
3	Inflammation (Inflammations) 04/2012 - 09/2000
3	Ischemia 03/2005 - 03/2001
2	Neoplasm Metastasis (Metastasis) 10/2016 - 01/2000
2	Infarction (Infarctions) 03/2005 - 03/2001
2	Adenocarcinoma 01/2005 - 10/2000
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2005 - 05/2003
2	Neuroblastoma 05/2003 - 06/2001
2	Colorectal Neoplasms (Colorectal Cancer) 05/2003 - 06/2000
2	Infections 11/2001 - 07/2001
2	Alcoholism (Alcohol Abuse) 10/2001 - 07/2001
2	Neointima 05/2001 - 02/2000
2	Pathologic Constriction (Stenosis) 12/2000 - 09/2000
1	Squamous Cell Carcinoma of Head and Neck 10/2016
1	Liver Neoplasms (Liver Cancer) 05/2014
1	Pathologic Processes 02/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2012
1	Pain (Aches) 03/2012
1	Brain Ischemia (Cerebral Ischemia) 03/2005
1	Endometrial Hyperplasia 01/2005
1	Lipoma (Lipomata) 03/2004
1	Ovarian Epithelial Carcinoma 03/2004
1	Atrioventricular Block 02/2004
1	Hepatocellular Carcinoma (Hepatoma) 09/2003
1	Hemorrhage 09/2003
1	Aneurysm (Aneurysms) 09/2003
1	HIV Infections (HIV Infection) 01/2003
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 11/2002
1	Farber Lipogranulomatosis 11/2002
1	Septic Shock (Toxic Shock Syndrome) 12/2001

Drug/Important Bio-Agent (IBA)

15	MidkineIBA 03/2005 - 01/2000
7	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2003 - 02/2000
5	Heparin (Liquaemin)FDA LinkGeneric 05/2003 - 02/2000
5	Proteins (Proteins, Gene)FDA Link 01/2003 - 02/2000
4	Messenger RNA (mRNA)IBA 05/2003 - 06/2000
4	Aldehyde DehydrogenaseIBA 05/2003 - 03/2000
3	IntegrinsIBA 04/2018 - 07/2000
3	Thymidine KinaseIBA 03/2001 - 01/2000
2	Pharmaceutical PreparationsIBA 02/2014 - 01/2000
2	DNA (Deoxyribonucleic Acid)IBA 04/2012 - 03/2001
2	Cadherins (E-Cadherin)IBA 04/2012 - 01/2000
2	Glucose (Dextrose)FDA LinkGeneric 04/2012 - 01/2000
2	Integrin beta4IBA 04/2010 - 08/2009
2	Nerve Growth Factors (Neurotrophins)IBA 03/2005 - 03/2001
2	pleiotrophin (HARP)IBA 03/2005 - 05/2003
2	Leu Transfer RNAIBA 01/2005 - 03/2004
2	OligodeoxyribonucleotidesIBA 05/2003 - 12/2001
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2003 - 10/2000
2	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 01/2003 - 04/2001
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 12/2001 - 04/2000
2	Indicators and Reagents (Reagents)IBA 12/2001 - 03/2001
2	AldehydesIBA 10/2001 - 03/2001
2	Ganciclovir (Cytovene)FDA LinkGeneric 03/2001 - 01/2000
1	deoxyhypusine synthaseIBA 10/2016
1	Factor VaIBA 10/2016
1	hypusineIBA 10/2016
1	MicroRNAs (MicroRNA)IBA 05/2014
1	3-deazaneplanocinIBA 05/2014
1	Vorinostat FDA Link 05/2014
1	Enhancer of Zeste Homolog 2 ProteinIBA 05/2014
1	Coffee FDA Link 04/2012
1	AdiponectinIBA 04/2012
1	LeptinIBA 04/2012
1	EnzymesIBA 04/2012
1	LipidsIBA 04/2012
1	cyclopropapyrroloindoleIBA 03/2012
1	Laminin (Merosin)IBA 04/2010
1	KalininIBA 08/2009
1	Keratin-14 (Keratin 14)IBA 08/2009
1	Biomarkers (Surrogate Marker)IBA 01/2007
1	OsteopontinIBA 01/2007
1	Syndecan-1 (Syndecan 1)IBA 03/2006
1	triphenyltetrazoliumIBA 03/2005
1	beta-Galactosidase (Lactaid)IBA 03/2005
1	Hormones (Hormone)IBA 01/2005
1	Progesterone FDA LinkGeneric 01/2005
1	Dichlorodiphenyldichloroethane (DDD)IBA 02/2004
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 09/2003
1	Polyethylene Terephthalates (Polyethylene Terephthalate)IBA 09/2003
1	Phosphotungstic Acid (Acid, Phosphotungstic)IBA 02/2003
1	Hematoxylin (Haematoxylon)IBA 02/2003
1	Coloring Agents (Dyes)IBA 02/2003
1	Matrix Metalloproteinases (MMPs)IBA 01/2003
1	Cyclophilin AIBA 01/2003
1	Acid CeramidaseIBA 11/2002
1	CeramidesIBA 11/2002
1	Syndecan-4IBA 12/2001
1	atelocollagenIBA 12/2001

Therapy/Procedure

5	Therapeutics 01/2005 - 08/2000
3	Stents 09/2001 - 09/2000
2	Transplantation 11/2001 - 07/2001
1	Dentures 03/2012
1	Gingivectomy 08/2009
1	Drug Therapy (Chemotherapy) 03/2004
1	Sutures (Suture) 09/2003
1	Aftercare (After-Treatment) 12/2001